Von Rickenbach Josef H

DirectorRein Therapeutics, Inc. (RNTX) · full profile →Form 4 · filed May 28, 2026
Net Buying
Open-Market Buys
$50K
Open-Market Sells
$0
Net Open-Market Flow
$50K
Transactions
4
4 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 27, 2026Buy(P)5K$1.07$5K63K
May 26, 2026Buy(P)23K$1.06$24K58K
May 22, 2026Buy(P)16K$1.05$17K35K
May 21, 2026Buy(P)3K$1.04$4K19K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-245832) within minutes of acceptance. Every field above traces to the original document. Verify it directly: